Clinical trial
Prospective Electronic Polygenic Risk Study (PEPRS) - First Phase
NCT05072275 is registered in ClinicalTrials.gov with Scripps Translational Science Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Electronic Polygenic Risk Study (PEPRS) - First Phase
- Lead sponsor
- Scripps Translational Science Institute
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 31, 2023
- Completion date
- November 30, 2023
- Enrollment
- 1,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.